Europace Advance Access originally published online on August 4, 2009
Europace 2009 11(9):1142-1150; doi:10.1093/europace/eup194
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS
Ablation within the sinus of Valsalva for treatment of supraventricular and ventricular tachycardias: what is known so far?
Department of Cardiology, Schwarzwald-Baar-Klinikum Villingen-Schwenningen, Academic Hospital of the University of Freiburg, Vöhrenbacherstr. 23-27, Villingen-Schwenningen 78050, Germany
Whenever common ablation strategies for treatment of cardiac arrhythmias fail, the search for alternative concepts becomes essential. Since it has been proven that the sinus of Valsalva (soV) is situated in close proximity to small regions of the myocardium, difficult to access via endocardial ablation, catheter ablation within the soV has become an established treatment option for patients with supraventricular and ventricular tachycardias. Although ablation within the soV is increasingly practiced, larger studies investigating the feasibility and safety of this approach remain rare. In this review, the authors summarize the currently available literature with special focus on safety issues, energy sources, success rates, and other distinctive aspects of ablation strategies within the soV.
Key Words: Sinus of Valsalva, Aortic cusp, Ablation, Atrial tachycardia, Supraventricular tachycardia, Ventricular tachycardia
* Corresponding author. Tel: +49 7721 93 3064; fax: +49 7721 93 3099. E-mail address: arillig5{at}yahoo.de
Manuscript submitted 6 April 2009. Accepted after revision 25 June 2009.